JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McAllister, R. J.
Right arrow Articles by Dittert, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McAllister, R. J.
Right arrow Articles by Dittert, L. W.

The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram

RG McAllister , DW Bourne and LW Dittert

The elimination kinetics of verapamil, an experimental antiarrhythmic agent which inhibits slow-channel activity, have been studied in mongrel dogs after i.v. drug administration. The disposition of verapamil follows first-order kinetics and may be adequately described by a one-compartment model. After single i.v. doses of the drug, the overall elimination rate constant (mean +/-S.E.M.) was 0.0146 +/- 0.0021 min-1; the apparent volume of distribution was 4.47 +/- 0.40 liters/kg; and the total body drug clearance was 1244 +/- 113.4 ml/min. After longer i.v. infusions, the disposition kinetics were similar to those found with bolus dosing. A linear relationship was found between verapamil plasma concentrations and changes in atrioventricular conduction time, as estimated from the P-R interval of the surface electrocardiogram (r = 0.95, P less than .001). No changes were seen in the QRS duration of Q-T interval. These data show that the effect of verapamil of verapamil on slow-channel-dependent conduction in the heart is directly related to the concentration of the drug in plasma.

Volume 202, Issue 1, pp. 38-44, 07/01/1977
Copyright © 1977 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
C. A. Evans, L. J. Jolivette, R. Nagilla, and K. W. Ward
EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF "DISCOVERY-LIKE" MOLECULES TO PREDICT HUMAN PHARMACOKINETICS
Drug Metab. Dispos., July 1, 2006; 34(7): 1255 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
K. Hirota, E. Hashiba, H. Yoshioka, S. Kabara, and A. Matsuki
Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation
Br. J. Anaesth., May 1, 2003; 90(5): 671 - 675.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. F. Huang, R. N. Upton, D. Zheng, C. Mclean, E. C. Gray, and C. Grant
The Enantiomer-Specific Kinetics and Dynamics of Verapamil after Rapid Intravenous Administration to Sheep: Physiological Analysis and Modeling
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1048 - 1057.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics.